Common Stock, Shares, Outstanding of CATALYST PHARMACEUTICALS, INC. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
CATALYST PHARMACEUTICALS, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • CATALYST PHARMACEUTICALS, INC. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 122,513,621, a 1.4% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

CATALYST PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 122,513,621 +1,634,522 +1.4% 31 Dec 2025 10-K 25 Feb 2026 2025 FY
Q3 2025 123,264,583 +3,998,022 +3.4% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 122,385,569 +3,864,203 +3.3% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 121,959,172 +3,929,646 +3.3% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 120,879,099 +13,757,550 +13% 31 Dec 2024 10-K 25 Feb 2026 2025 FY
Q3 2024 119,266,561 +12,661,554 +12% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 118,521,366 +12,020,107 +11% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 118,029,526 +12,091,234 +11% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 107,121,549 +1,858,518 +1.8% 31 Dec 2023 10-K 26 Feb 2025 2024 FY
Q3 2023 106,605,007 +2,540,324 +2.4% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 106,501,259 +3,791,911 +3.7% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 105,938,292 +2,981,607 +2.9% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 105,263,031 +2,270,118 +2.2% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 104,064,683 +911,224 +0.88% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 102,709,348 -452,693 -0.44% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 102,956,685 -847,905 -0.82% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 102,992,913 -788,728 -0.76% 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q3 2021 103,153,459 -494,765 -0.48% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 103,162,041 -259,991 -0.25% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 103,804,590 +395,891 +0.38% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 103,781,641 +384,608 +0.37% 31 Dec 2020 10-K 16 Mar 2022 2021 FY
Q3 2020 103,648,224 +607,191 +0.59% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 103,422,032 +492,775 +0.48% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 103,408,699 +604,442 +0.59% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 103,397,033 +657,776 +0.64% 31 Dec 2019 10-K 15 Mar 2021 2020 FY
Q3 2019 103,041,033 +351,776 +0.34% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 102,929,257 +329,999 +0.32% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 102,804,257 +218,093 +0.21% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 102,739,257 +189,759 +0.18% 31 Dec 2018 10-K 16 Mar 2020 2019 FY
Q3 2018 102,689,257 +17,454,278 +20% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 102,599,258 +18,044,279 +21% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 102,586,164 +19,613,848 +24% 31 Mar 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 102,549,498 +19,577,182 +24% 31 Dec 2017 10-K 18 Mar 2019 2018 FY
Q3 2017 85,234,979 +2,364,330 +2.9% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 84,554,979 +1,684,330 +2% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 82,972,316 +101,667 +0.12% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 82,972,316 +121,697 +0.15% 31 Dec 2016 10-K 14 Mar 2018 2017 FY
Q3 2016 82,870,649 +175,577 +0.21% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 82,870,649 +773,843 +0.94% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 82,870,649 +860,800 +1% 31 Mar 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 82,850,619 +13,731,527 +20% 31 Dec 2015 10-K 15 Mar 2017 2016 FY
Q3 2015 82,695,072 +15,525,689 +23% 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 82,096,806 +14,927,423 +22% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 82,009,849 +27,864,216 +51% 31 Mar 2015 10-Q 11 May 2015 2015 Q1
Q4 2014 69,119,092 +14,986,155 +28% 31 Dec 2014 10-K 15 Mar 2016 2015 FY
Q3 2014 67,169,383 +13,182,446 +24% 30 Sep 2014 10-Q 13 Nov 2014 2014 Q3
Q2 2014 67,169,383 +25,698,696 +62% 30 Jun 2014 10-Q 13 Aug 2014 2014 Q2
Q1 2014 54,145,633 +12,724,946 +31% 31 Mar 2014 10-Q 15 May 2014 2014 Q1
Q4 2013 54,132,937 +12,712,250 +31% 31 Dec 2013 10-K 13 Mar 2015 2014 FY
Q3 2013 53,986,937 +19,245,417 +55% 30 Sep 2013 10-Q 13 Nov 2013 2013 Q3
Q2 2013 41,470,687 +10,729,167 +35% 30 Jun 2013 10-Q 14 Aug 2013 2013 Q2
Q1 2013 41,420,687 +16,679,167 +67% 31 Mar 2013 10-Q 15 May 2013 2013 Q1
Q4 2012 41,420,687 +16,719,267 +68% 31 Dec 2012 10-K 19 Mar 2014 2013 FY
Q3 2012 34,741,520 +13,086,840 +60% 30 Sep 2012 10-Q 14 Nov 2012 2012 Q3
Q2 2012 30,741,520 +9,086,840 +42% 30 Jun 2012 10-Q 14 Aug 2012 2012 Q2
Q1 2012 24,741,520 31 Mar 2012 10-Q 15 May 2012 2012 Q1
Q4 2011 24,701,420 +5,306,683 +27% 31 Dec 2011 10-K 01 Apr 2013 2012 FY
Q3 2011 21,654,680 30 Sep 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 21,654,680 30 Jun 2011 10-Q 15 Aug 2011 2011 Q2
Q4 2010 19,394,737 31 Dec 2010 10-K 30 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.